This is a great new opportunity to attend an event for business development executives from Swiss and European pharma and biotech companies seeking to work with partners from China to expand into the Chinese market.
The European-Chinese Pharma Partnering Event 2018 offers insights into the rapidly evolving Chinese pharma and biotech industry, its established as well as emerging players and their strategy to expand their capabilities and portfolios. Join us for an exclusive opportunity to meet Chinese executives looking to partner with Western pharma and biotech companies. The focus of this dedicated partnering event is to help life sciences companies find strategic partners, market expansion and/or funding in China. The two-day program consists of two parts: the main conference with industry speakers and company presentations, and separate partnering meetings (by invitation only).
The European-Chinese Pharma Partnering Event 2018 may be just the beginning of your relationship with the surging Chinese pharma industry.
Friday, October 12th, 2018: Switzerland Innovation Park Basel Area, Gewerbestrasse 24, 4123 Allschwil, Switzerland
Organized by the Swiss Biotech Association & supported by the Swiss Healthcare Licensing
The Swiss Biotech Day is the leading biotechnology conference in Switzerland, with two editions, one in spring and one in fall. Join Swiss Biotech Day Fall, coinciding with Europa BIO’s European Biotech Week, to meet senior executives from the Swiss biotech industry – entrepreneurs, investors, researchers, analysts, political decision-makers Group and stakeholders.
This year’s half-day program focuses on lessons to be learned from the race to innovate, with perspectives from drug developers, investors and academia. Networking opportunities accompany plenary sessions.
The conference takes place at the Aquatis Hotel, September 27th, 2018, 1 pm to 6 pm.
The registration fee for Swiss HLG members is only 50 CHF
Both Swiss HLG and PCLF invited speakers from both countries to share with the audience their successes and above all how partnering influenced success.
Once again, attendance was a real success with around 130 delegates from Switzerland, France, Germany and other European countries.
The conference started with an insightful introduction from Patrick Aebischer, President emeritus, Brain Mind Institute at EPFL, on critical components and factors to build a successful innovation ecosystem between universities, research institutes, tech transfer offices, accelerator, and entrepreneurship.
Following the opening keynote, we had a series of inspiring presentations held by Jurgi Camblong (CEO of SOPHiAGENETICS), Mondher Majoubi (CEO of Innate Pharma), Hervé Affagard (CEO MaaT Pharma), Andreas Emmenegger (CFO of Molecular Partners). Beyond great insights on their promising technologies, participants could learn how they embraced partnering as a cornerstone strategy for the development of their company.
The event closed after a great panel moderated by Marc Ceulemans (Head of Strategic Investment from Novartis), with Michele Ollier (Partner atMedixci), Christoph Kausch (Partner at MTIP), Jean-Philippe Tripet (Partner at Aravis) and Marie Petit (Principal at Villiger Valuation) which touched on various topics such as cultural differences when building and financing start-ups between Europe and the US; key success factors for a start-up, and financing challenges in some countries.
Last but not least, for the first time, we interviewed some of our speakers, and we will be pleased to share their insights very soon.
Please find below some images from the conference. (Please click on the image to view it in its entirety and or a slide show.)
The Swiss Healthcare Licensing Group and the Pharma Licensing Club France are delighted to invite you to an event featuring key success stories of innovative companies in Switzerland and France. Companies active in the field of microbiome, immuno-oncology, digital and virtual reality or data analysis will address some of the key challenges they faced during the innovation, financing and deal-making processes.
Along with our partners Pharma Licensing Club France, we have prepared a great line up of distinguished speakers. They will discuss the topic: “INNOVATION IN HEALTHCARE: FROM TECHNOLOGY TO BUSINESS MODELS AND TRANSACTIONS.”
This exciting one day conference will be held on May 16th, 2018, at the Novartis Campus, Basel in Switzerland.
Come and join us, for an informative day which is not only an excellent platform for networking with colleagues but also a good place to showcase and attract partners to your organization.
Registration cost: including Networking Lunch & Breaks
Swiss HLG Member/PLCF Member Rate € 130
Non-Member Rate € 150
the number of seats/attendees is limited, register now!
Register now >> https://swisshlg.ngaevents.co.uk/swisshlg-basel/
We look forward to seeing you there.